Sanofi

LANTUS SOLOSTAR PEN

Manufacturer:

Sanofi

Lantus Solostar Pen HCPCS:

S5553

HCPCS Code Descriptor:

Insulin, long acting; 5 units

Category:

S Code

Lantus Solostar Pen NDCs:

00088-2219-05, 00169-3687-12

Primary Type:

Insulin

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00088-2219-05

About Lantus Solostar Pen:

LANTUS SOLOSTAR PEN is an Insulin drug manufactured by Sanofi and administered via the Subcutaneous route of administration. The S Code: S5553 is aligned to the drug LANTUS SOLOSTAR PEN.

ACCESS PRICING AND MORE BY REGISTERING

S5553 Added Date:

October 1, 2003

S5553 Effective Date:

October 1, 2003

S5553 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lantus Solostar Pen billing and coding information.
Our team did not identify a source for Lantus Solostar Pen patient assistance information. Please reach out to our team if you feel that this is a mistake.
LANTUS SOLOSTAR PEN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for LANTUS SOLOSTAR PEN. Please check back in a few weeks.